Fingerprint
Dive into the research topics of 'GLP-1 agonist-based therapies: An emerging new class of antidiabetic drug with potential cardioprotective effects'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
GLP-1 agonist-based therapies: An emerging new class of antidiabetic drug with potential cardioprotective effects
Melanie Sulistio, Curtis Carothers, Mandeep Mangat, Mike Lujan, Rene Oliveros, Robert Chilton
Research output: Contribution to journal › Article › peer-review
25
Scopus
citations